Atenolol

CHEMBL24 Phase 4 承認済み Small molecule
Half-Life
6-7 hours
Bioavailability
Protein Binding
Molecular Weight
266.3 g/mol
LogP
0.2
Phase
4

A beta-1 selective adrenergic blocker that slows the heart rate and reduces the force of heart contractions, lowering blood pressure and decreasing the heart's oxygen demand. It is used for hypertension, angina, and heart rhythm disorders including atrial fibrillation.

分子量

266.3360 g/mol

LogP

0.20

TPSA

84.60 Ų

リピンスキーの五則

適合

治療領域

薬物分類

作用機序

Cardioselective beta-1 adrenergic receptor blocker without intrinsic sympathomimetic activity.

Pharmacokinetics (PK)

Half-Life 6-7 hours

Pharmacodynamics (PD)

機序

Cardioselective beta-1 adrenergic receptor blocker without intrinsic sympathomimetic activity.

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(C)NCC(O)COc1ccc(CC(N)=O)cc1

InChI

InChI=1S/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)

Molecular Formula

C14H22N2O3

HBD / HBA

3 / 4

回転可能結合数

8

重原子数

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A beta-1 selective adrenergic blocker that slows the heart rate and reduces the force of heart contractions, lowering blood pressure and decreasing the heart's oxygen demand. It is used for hypertension, angina, and heart rhythm disorders including atrial fibrillation.

Cardioselective beta-1 adrenergic receptor blocker without intrinsic sympathomimetic activity.

Key pharmacokinetic parameters for Atenolol: Half-life: 6-7 hours.

Yes, Atenolol is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

Related Drugs

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL24. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 2249. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.